share_log

Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6

Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6

富瑞將第三諧波生物降級為持有,將目標價格降至 3.6 美元
Benzinga Real-time News ·  2022/12/16 06:02

Jefferies analyst Akash Tewari downgrades Third Harmonic Bio (NASDAQ:THRD) from Buy to Hold and lowers the price target from $30 to $3.6.

傑富瑞分析師Akash Tewari將Third Harmonic Bio(納斯達克:TRAD)的評級從買入下調至持有,並將目標價從30美元下調至3.6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論